When a women gets temporary diabetes during pregnancy its called gestational diabetes. Doctors are now saying that the number of women getting this temporary case of diabetes during pregnancy is rising. Even worse, they now believe that the chances of a women who previous had gestational diabetes are 5 times greater to develop type 2 diabetes later in life.

The numbers are staggering, 50% of women with gestational diabetes developer type 2 diabetes in the 5 years after their pregnancy. 70% will develop type 2 diabetes in the 28 years are their pregnancy. The good news is that only 8% of pregnant women develop gestational diabetes. Those 8% tend to have a family history of diabetes, are out of shape, over weight.

What causes gestational diabetes? It occurs when the mothers glucose level is too high, the baby can get too big and have very low glucose levels are birth (aka hypoglycemia)

The thing that most doctors say will help prevent gestational diabetes, is not being overweight. they now encourage women before they get pregnant to lose weight and get in shape.

Women with Gestational Diabetes 5x more likely to develop type 2 diabetes when they get older. is from: Diabetes Insider.com

Related posts:

1. Gestational Diabetes
2. Colon Cancer Threaten Women with Diabetes
3. Diabetes on the rise among older Mexican Americans

A group of Doctors looking for new and innovative ways to better care for patients with diabetes, are starting to consider and plan for group checkins. They are looking to start with diabetes as well as high blood pressure.

These group checkins will be longer than the avg visit , from and hour and half to two hours. The extended time will allow the patients to ask the Doctor more questions, hear more tips for managing their diabetes, and get a chance to learn from other patients in addition to the doctor.

This is an important move, as over time doctors caring for patents with diabetes have less and less time to spend with the patients and teach them how to manage their disease.

We here at Diabetes insider will continue to monitor and report on this group checkin trend.

Is Group Checkins a good idea for Diabetes Patients? is from: Diabetes Insider.com

Related posts:

1. Diabetic Patients get extra care from CVS pharmacy
2. Patients on Cancer Prostate Drugs Potential to Get Diabetes and Heart Problems
3. Avandia Leads Heart Attack

The drug was designed to be used with exercise and diet to control type 2 diabetes in adults. The drug was born out of a partnership of Eli Lilly & Boehringer Ingelheim that was signed un January. The partnership calls for the two compaines to co-develop 5 drugs for diabetes patients.

Tradjenta is a tablet. Tradjenta was tested by the FDA and was found to be 8 different controlled studies. The studies showed Tradjenta helps with blood glucose control.

Like all medicine, Tardjenta will be packaged and distributed with an insert that details the drugs uses & possible risks and side effects.

Breaking: FDA Officially Approves Diabetes Drug Tradjenta is from: Diabetes Insider.com

Related posts:

1. Diabetes Drug Byetta Rejected by FDA
2. FDA Decision to Reconsider Bydureon
3. Neurocrine Boehringer Deal, A milestone in Diabetes Drug development

Related posts:

1. Diabetes News: Mediterranean diet better than low fat diet for diabetics – Food Consumer
2. The Diabetes & Heart Healthy Cookbook
3. The All-Natural Diabetes Cookbook

Related posts:

1. Dr. Neal Barnard’s Program for Reversing Diabetes: The Scientifically Proven System for Reversing Diabetes without Drugs
2. Reversing Diabetes
3. Reversing Diabetes Cookbook: More Than 200 Delicious, Healthy Recipes

Related posts:

1. What Your Doctor May Not Tell You About Diabetes: An Innovative Program to Prevent, Treat, and Beat This Controllable Disease
2. The Weight Loss Plan for Beating Diabetes: The 5-Step Program That Removes Metabolic Roadblocks, Sheds Pounds Safely, and Reverses Prediabetes and Diabetes
3. Diabetes Diet Cookbook: Discover the New Fiber-FULL Eating Plan for Weight Loss

Related posts:

1. The Best Life Guide to Managing Diabetes and Pre-Diabetes
2. The New Glucose Revolution for Diabetes: The Definitive Guide to Managing Diabetes and Prediabetes Using the Glycemic Index (Marlowe Diabetes Library)
3. Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin

Related posts:

1. The 30-Day Diabetes Miracle: Lifestyle Center of America’s Complete Program for Overcoming Diabetes, Restoring Health, and Rebuilding Natural Vitality
2. The 30 Day Diabetes Miracle Cookbook: Stop Diabetes with an Easy-to-Follow Plant-Based, Carb-Counting Diet
3. Diabetes Type 2: Complete Food Management Program

Related posts:

1. Eat & Beat Diabetes with Picture Perfect Weight Loss: The Visual Program to Prevent and Control Diabetes
2. 50 Diabetes Myths That Can Ruin Your Life: And the 50 Diabetes Truths That Can Save It
3. Diabetes Without Drugs the 5-step Program to Control Blood Sugar Naturally and Prevent Diabetes Complications

Tata group company Advinus Therapeutics has completed initial trials of a new molecule to treat type II diabetes and is in talks with a few global drugmakers to outlicense the molecule, a top company executive said.

The privately held company has sought the Indian drug regulator’s nod to go ahead with the phase II (a) trial of its molecules in multiple dosages, which essentially means trying it out on a larger number of patients and healthy individuals.

If the molecule is commercialised it could have a significantly higher efficacy and safety profile over the existing drugs available in market to treat the diabetes in the market, Rashmi Barbhaiya, CEO and managing director, Advinus Therapeutics said.

About Advinus: Advinus Therapeutics (a TATA enterprise is an integrated R &D organization that is focused on the new drug discovery and development of pharmaceuticals and agrochemicals. The company is the first of its kind in India to offer end to end development services to the global pharma, agro and biotech industry while creating long term value through internal and collaborative Drug Discovery. Advinus operations are organized into two separate business centered on Discovery (Pune-India) and Development (Bangalore-India) respectively. Advinus has over 450 professionals more than 60% being Masters and Ph D degree holders.

via: indiatimes.com

Advinus Considering Licensing Molecule the Diabetes Drug is from: Diabetes Insider.com

Related posts:

1. Neurocrine Boehringer Deal, A milestone in Diabetes Drug development
2. Surprising Fact: Metformin in Diabetes Drug Effectively Treat Certain Type of Cancer
3. New Finding on Popular Diabetes Drug

The majority of people with diabetes who had bariatric surgery to lose weight were able to stop taking their diabetes medications, which led to a significant decline in health-care costs, according to a study released Monday.

Researchers at Johns Hopkins in Baltimore, looked at 2,235 adults who had the stomach-reducing surgery and who also had Type 2 diabetes, a common form of the disease often associated with weight gain. Six months after surgery, nearly 75% of patients had eliminated their diabetes medications and after two years 84.5% of patients were off medicine.

The study, published in this month’s Archives of Surgery, a Journal of the American Medical Association publication, was funded by the Department of Health and Human Services.

Many patients were able to stop taking their medications almost immediately after surgery and before they’d lost large amounts of weight, backing theories that stomach hormones altered by surgery are better able to control blood glucose levels than weight loss alone.

“Until a successful nonsurgical means for preventing and reversing obesity is developed, bariatric surgery appears to be the only intervention that can result in a sustained reversal of both obesity and Type 2 diabetes in most patients receiving it,” said, Martin Makary, the study’s lead researcher and an associate professor of surgery at the Johns Hopkins University School of Medicine.

Dr. Makary said the majority of patients were able to stop taking other types of medications, such as high-blood pressure pills.

About 86% of the patients, who were covered by Blue Cross and Blue Shield insurance, were on at least one diabetes medication before surgery, with an average of 4.4 medications per patient. About 23% of patients were on insulin.

via WSJ

written by Jenifer Corbet Doren

Surgery To Reduce Drugs Needed by Diabetics (Study) is from: Diabetes Insider.com

Related posts:

1. Patients on Cancer Prostate Drugs Potential to Get Diabetes and Heart Problems
2. Obesity in Diabetes are linked to their Economic conditions
3. Diet, Drugs & Exercise Factors In Controlling Adult Onset Diabetes

Shocking Evidence has been found that type 2 diabetes increases the risk to get certain cancer. Based on the study shown by American Cancer Association and American Diabetes Association, type 2 diabetes has been linked to certain cancer that will make more complicated for diabetic patients.

As you know, diabetes is categorized as a very dangerous epidemic that must be prevented earlier. Susan Gapstur, the vice president of American Cancer Society gives the fact about certain cancers that are linked to type 2 diabetes; they are liver cancer, colorectal cancer, breast cancer, pancreatic cancer, and bladder cancer.

Furthermore, professional researchers work hard to get the factors, causes and the best treatments to overcome this fact. It really needs accurate research to make sure the patients about the best drugs for type 2 diabetic patients. If it is not, the complication may occur in type 2 diabetic patients. Fortunately, the best drug has been found to treat type 2 diabetes and reduced the risk to get cancer. Researchers are sure that metformin is the right drug treatment for type 2 diabetic patients.

Type 2 diabetes has been linked to certain cancer because of the high insulin level, glucose level, and fat. Based on Susan Gapstur’s statements, the risk of cancer can be decreased by doing healthy lifestyle. Set a healthy diet and do exercises to reduce fat, effectively. Visit your doctor based on the schedule, talk and share about your disease, do cancer screening earlier to detect cancer symptoms so that you will be ready for the next treatment.

Diabetes Information

Type 2 Diabetes Has Been Linked to Certain Cancer is from: Diabetes Insider.com

Related posts:

1. Revealing the Relation between Type 2 Diabetes and Cancer Incidence
2. Colon Cancer Threaten Women with Diabetes
3. Surprising Fact: Metformin in Diabetes Drug Effectively Treat Certain Type of Cancer

Neurocrine Biosciences Inc (NBIX.O) has recently signed a deal with Boehringer Ingelheim which is a private German drug manufacturing company. Under the terms of the huge deal Neurocrine has assigned a task of developing drug candidates in order to treat Type 2 diabetes and other related symptoms.

According to Neurocirine, Boehringer Ingelheim is responsible for the development and commercialization of potential GPR 119 agonist products in global market. Therefore these drug maker companies will produce agonist product comprising small molecules which will be used to activate GPR 119 which will induce insulin production.

Actually GPR119 is a G protein-coupled receptor which is present in the digestive system and pancreatic islet belt. Therefore its activation by small molecules of agonist product will induce the production of insulin.

Jon LeCroy, a Hapoalim Securities analyst, added that this great deal between two giant companies has brought substantial financial support for Neurocrine to push its pipeline products ahead with no need of colossal expenditure for this purpose.

This deal really has brought positive prospects for Neurocrine which is expected to receive a huge amount of $10 million as upfront payment and will received $225 million as milestone payment. The purpose of providing such huge sum in upfront payment is to support and facilitate the whole discovery process.

Moreover on Wednesday, Neurocrine signed another deal with Abbott laboratories Inc (ABT.N) for the development and commercialization of its experimental products which will be used to treat endometrioses.

Due to these positive developments the shares of Neurocrine raised up to 8 percent to touch 52-week high of $5.79 in trade on Nasdaq.

Daily Diabetes News

Neurocrine Boehringer Deal, A milestone in Diabetes Drug development is from: Diabetes Insider.com

Related posts:

1. Breaking: FDA Officially Approves Diabetes Drug Tradjenta
2. Diabetes Drug Byetta Rejected by FDA
3. Advinus Considering Licensing Molecule the Diabetes Drug

Recent research conducted by US experts over the factors increasing the probability of Type 2 diabetes concluded that white rice which have potential to raise diabetes risk must be replaced by brown rice or whole grains to lessen the risk factor up to one third.

According to Harvard researchers in Archives of Internal Medicine, white rice plays active role in increasing the level of blood sugar while brown rice and other whole grain foods gradually release food energy and keep the blood sugar level normal.

In a study involving almost 200,000 US people proved that those who have consumed five or more 150g servings in one week showed 17% greater risk of having diabetes as compared to those who have consumed only a cup of rice per month.

According to Dr Victoria King Diabetes UK the best way to prevent the risks of Type 2 diabetes is to consume healthy food items having low fat and low sugar ratio along with fresh fruits and vegetables.
Dr Qi Sun also added that main issue is related with the composition of food we consume. Whole grain foods are high in fibre and release energy slowly while white rice with its higher glycaemic index (GI) has greater potential to release energy more readily which results in higher level of blood sugar.

Research proved that almost 70% rice consumption in US and UK comprises white rice which must be replaced by whole grains to prevent the risk of Type 2 diabetes among rice consumers.

Daily Diabetes News from Diabetes Insider

White Rice Consumption – Another Alarming Sign in Type 2 Diabetes is from: Diabetes Insider.com

Related posts:

1. HbA1c Test important for black children
2. How to Prevent Diabetes
3. Revealing the Relation between Type 2 Diabetes and Cancer Incidence

Good News! With the current onslaught of diabetes across the Canada and the rest of the world – Canada’s UOIH (University of Ottawa Heart Institute) will use in hospital diabetes screening to help find diagnose people with diabetes. As you know, diabetes tends to be difficult to be detected. It is not a simple disease. In fact, diabetes is classified as a silent killer that will kill people around the world, especially in Western Hemisphere.

Let see the true record about the late diabetes detection! Based on the study that is done by UOIH (University of Ottawa Heart Institute), more than 10% heart disease patients have diabetes. Unfortunately, they do exactly not know this dangerous disease has been affected in their body.
Growth of diabetes is significant in the West, especially for women who have heart disease. If you see the fact, you will know that diabetes as a dangerous epidemic easily affects women than men. Most women die because of diabetes complications such as a heart disease. No matter the ages, diabetes makes people give up living. Moreover, diabetes medical treatment cost is quite expensive. In fact, every year price of diabetes medical treatment is increasing.

Because of these cases, UOIH creates medical invention, named screening diabetes program to detect diabetes earlier. It has beneficial purposes to diagnose diabetes and set the best treatment to overcome diabetes earlier. Therefore, there is no more late diabetes diagnose for patients. In addition, it can be used to give warning for people avoiding the bad risks of this dangerous epidemic. Furthermore, UOIH gives universal services for local and international to save people’s soul.

Diabetes Information

In-Hospital Diabetes Screening at the Heart Institute in Ottawa is from: Diabetes Insider.com

Related posts:

1. Avandia Leads Heart Attack
2. Patients on Cancer Prostate Drugs Potential to Get Diabetes and Heart Problems
3. Prochymal as Type 1 Diabetes Treatment